Alnylam Pharmaceuticals, Inc. (ALNY)
240.69
+3.59
(+1.51%)
USD |
NASDAQ |
Aug 31, 16:00
240.68
-0.01
(-0.00%)
After-Hours: 20:00
Alnylam Pharmaceuticals Total Long Term Debt (Quarterly) : 2.942B for June 30, 2026
Total Long Term Debt (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 2.942B |
| March 31, 2026 | 2.925B |
| December 31, 2025 | 2.923B |
| September 30, 2025 | 2.729B |
| June 30, 2025 | 2.694B |
| March 31, 2025 | 2.676B |
| December 31, 2024 | 2.702B |
| September 30, 2024 | 2.684B |
| June 30, 2024 | 2.667B |
| March 31, 2024 | 2.643B |
| December 31, 2023 | 2.641B |
| September 30, 2023 | 2.623B |
| June 30, 2023 | 2.604B |
| March 31, 2023 | 2.586B |
| December 31, 2022 | 2.571B |
| September 30, 2022 | 2.550B |
| June 30, 2022 | 2.193B |
| March 31, 2022 | 2.170B |
| December 31, 2021 | 2.145B |
| September 30, 2021 | 1.879B |
| June 30, 2021 | 1.850B |
| March 31, 2021 | 1.579B |
| December 31, 2020 | 1.556B |
| September 30, 2020 | 1.340B |
| June 30, 2020 | 1.296B |
| Date | Value |
|---|---|
| March 31, 2020 | 275.78M |
| December 31, 2019 | 276.14M |
| September 30, 2019 | 276.46M |
| June 30, 2019 | 307.21M |
| March 31, 2019 | 312.30M |
| December 31, 2018 | 30.00M |
| September 30, 2018 | 30.00M |
| June 30, 2018 | 30.00M |
| March 31, 2018 | 30.00M |
| December 31, 2017 | 30.00M |
| September 30, 2017 | 150.00M |
| June 30, 2017 | 150.00M |
| March 31, 2017 | 150.00M |
| December 31, 2016 | 150.00M |
| September 30, 2016 | 150.00M |
| June 30, 2016 | 150.00M |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Ionis Pharmaceuticals, Inc. | 2.189B |
| BridgeBio Pharma, Inc. | 3.370B |
| Regeneron Pharmaceuticals, Inc. | 2.707B |
| Vertex Pharmaceuticals, Inc. | 1.978B |
| Pfizer Inc. | 63.10B |